0% found this document useful (0 votes)
60 views33 pages

Advances in Pharmacology of Dyslipidemia: Clinical Aspects

This document discusses advances in the pharmacology of dyslipidemia. It begins by describing characteristic lipids like cholesterol, triglycerides, and phospholipids. Lipids are transported in the body by lipoproteins like LDL and HDL. The document then covers lipid metabolism and disorders of lipid metabolism. Dyslipidemias can cause cardiovascular diseases if not treated properly. Treatment involves lifestyle changes and medications like statins, fibrates, and niacin that target different types of dyslipidemia like high cholesterol, high triglycerides, and low HDL. The goals of treatment are to lower lipid levels and reduce cardiovascular risk.

Uploaded by

namar13766
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
60 views33 pages

Advances in Pharmacology of Dyslipidemia: Clinical Aspects

This document discusses advances in the pharmacology of dyslipidemia. It begins by describing characteristic lipids like cholesterol, triglycerides, and phospholipids. Lipids are transported in the body by lipoproteins like LDL and HDL. The document then covers lipid metabolism and disorders of lipid metabolism. Dyslipidemias can cause cardiovascular diseases if not treated properly. Treatment involves lifestyle changes and medications like statins, fibrates, and niacin that target different types of dyslipidemia like high cholesterol, high triglycerides, and low HDL. The goals of treatment are to lower lipid levels and reduce cardiovascular risk.

Uploaded by

namar13766
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 33

ADVANCES IN PHARMACOLOGY OF DYSLIPIDEMIA

Clinical aspects
roda, 10 kwietnia 2013

PLAN
lipids characteristic lipids metabolism diseases connected with lipids the classification of dyslipidemic disorders the treatment of hiperlipidemias
roda, 10 kwietnia 2013

Cholesterol and lipids characteristic


lipid - substance with poor water solubility biologically important lipids:
cholesterol

sterols (composition of hydrocarbon rings) glycerides (composition of hydrocarbon chains)

TG & phospholipids

roda, 10 kwietnia 2013

Cholesterol and lipids characteristic


assimilated from the diet after digestion transported in the body by incorporating lipids within lipoproteins LIPOPROTEIN = apolipoprotein+free cholesterol+phospholipid+TG +cholesteryl ester

roda, 10 kwietnia 2013

Cholesterol and lipids characteristic


LIPOPROTEIN:
apolipoprotein - a protein that binds to lipids (Apo A, Apo B, Apo C, Apo E) free cholesterol phospholipid (glycerol, two fatty acids, choline phosphate, an emulsifier like lecithin) trigliceride - an ordinary fat molecule (glycerol and three fatty acids) cholesteryl ester(a compound of cholesterol and a fatty acid)

roda, 10 kwietnia 2013

Cholesterol and lipids characteristic


LIPOPROTEIN:

roda, 10 kwietnia 2013

Cholesterol and lipids characteristic


CLASSIFICATION OF LIPOPROTEINS
Chylomicrons Very Low Density Lipoproteins (VLDL) intermediate Density Lipoproteins (IDL) Low Density Lipoproteins (LDL) High Density Lipoproteins (HDL)

roda, 10 kwietnia 2013

Cholesterol and lipids metabolism

roda, 10 kwietnia 2013

Cholesterol and lipids metabolism

roda, 10 kwietnia 2013

Reverse cholesterol transport

roda, 10 kwietnia 2013

roda, 10 kwietnia 2013

Clinical manifestations of hyperlipidemia


atherosclerosis cardiovascular diseases cardiac infarct cerebral infarct pancreatitis

roda, 10 kwietnia 2013

Classification of primary hyperlipidemia


predominant hypercholesterolemia: TCh, LDL, HDL predominant hypertriglicerydemia: TG, TCh(n), LDL(n) mixed hyperlipidemia: TG, TCh, LDL

roda, 10 kwietnia 2013

Clinical signs of hyperlipidemia


predominant hypercholesterolemia: xanthelsama (xanthoma), corneal arcus, extensor digitorum xantomas, Achilles tendon xanthomas, aortic stenosis, pre-patellar xanthomas predominant hypertriglicerydemia: lipaemia retinalis , lipemic blood and plasma, eruptive xanthomas, acute pancreatitis, hepatosplenomegaly mixed hyperlipidemia

roda, 10 kwietnia 2013

Clinical signs of hyperlipidemia


predominant hypercholesterolemia:

predominant hypertriglicerydemia:

roda, 10 kwietnia 2013

Causes of secondary hypercholesterolemia


hypothyroidism pregnancy cholestatic liver disese drugs (diuretics, ciclosporin, corticosteroids, androgens) nephrotic syndrome anorexia nervosa porphyria hyperparathyroidism

roda, 10 kwietnia 2013

Causes of secondary hypertriglyceridemia

diabetes mellitus chronic renal disease abdominal obesity excess alcohol hepatocellular disease drugs (beta-blockers, retinoids, corticosteroids)

roda, 10 kwietnia 2013

Metabolic syndrome
IDF criteria abdominal obesity M >=94cm; F >=88cm) elevated TG (>150mg/dl) Low HDL (M<40mg/dl; F<50mg/dl) elevated blood pressure (>130/85) elevated glycemia (>=100mg/dl)

roda, 10 kwietnia 2013

Metabolic syndrome
Increased cardiovascular risk Associated with atherogenic dyslipidemia low HDL high TG mildly elevated LDLs small dense LDLs
roda, 10 kwietnia 2013

Non-pharmacological treatment and prophylaxis

diet regular physical activity cessation of cigarettes limited alcohol usage

roda, 10 kwietnia 2013

DRUGS USED IN TREATING DYSLIPIDEMIA

statins fibrates niacin bile acid sequestrants ezetimibe omega-3 acids


roda, 10 kwietnia 2013

Treatment of hypercholesterolemia * statins * bile acid sequestrants * nicotinic acid * ezetimibe

roda, 10 kwietnia 2013

Treatment of hypertriglycerydemia * fibrates * statins * nicotinic acid * laropriprant * n-3 fatty acids

roda, 10 kwietnia 2013

Treatment of low HDL level * nicotinc acid * statins * fibrates

roda, 10 kwietnia 2013

WHEN TO TREAT HYPERLIPIDEMIA?

roda, 10 kwietnia 2013

WHEN TO TREAT HYPERLIPIDEMIA?

roda, 10 kwietnia 2013

WHEN TO TREAT HYPERLIPIDEMIA?

roda, 10 kwietnia 2013

WHEN TO TREAT HYPERLIPIDEMIA?

roda, 10 kwietnia 2013

Target lipid levels

roda, 10 kwietnia 2013

Drug increasing TG
corticosteroids estrogens (esp. taken orally) tamoxifen antihypertensives (betablockers, thiazides) isotretinoin bile acid-binding resins ciclosporin antiretroviral (protease inhibitors) psychotropics (phenothiazine, 2nd generation antipsychotics)
roda, 10 kwietnia 2013

Monitoring lipids and enzymes in patients on lipid-lowering therapy

Lipids

roda, 10 kwietnia 2013

Monitoring lipids and enzymes in patients on lipid-lowering therapy

CK

roda, 10 kwietnia 2013

Monitoring lipids and enzymes in patients on lipid-lowering therapy

Liver and muscles enzymes

roda, 10 kwietnia 2013

You might also like